The Novo Nordisk business is based on a clear vision, a strong set of core values and a consistent corporate governance model.

As a natural consequence, we have formulated positions on issues of relevance to our business and our role as a global corporate citizen: 

• Access to health
• Animal experimentation 
• Gene technology 
• Human rights 
• Intellectual property rights and patenting 
• Stem cells
• Use of non-human primates

The positions presented express our views as well as the context and the background for the position.

Below, Novo Nordisk contact persons are named, from whom more information on each issue can be obtained.

Media representatives are kindly asked to contact our Media Relations Team.

Issue	Contacts
Human rights	Elin Schmidt Vice President, Stakeholder Relations +45 4442 4042
Access to health	Stig Pramming Vice President, Stakeholder Relations +45 4442 65 34
IPR and patenting	Lars Kellberg Vice President, Business Development and Patents +45 4442 1822
Animal experimentation	Hanne Gürtler  Director, Bioethics Management +45 4442 2305
Gene technology	Henrik Kim Nielsen Vice President, Production Development +45 4442 6298
Stem cells	Mads Krogsgaard Thomsen Executive vice president and chief science officer +45 4442 3988
Non-human primates	Hanne Gürtler  Director, Bioethics Management +45 4442 2305